These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6216344

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Piperacillin therapy for Pseudomonas infections.
    Eron LJ, Goldenberg RI, Poretz DM, Park CH.
    South Med J; 1983 Jul; 76(7):859-62. PubMed ID: 6223378
    [Abstract] [Full Text] [Related]

  • 23. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J, Russo ME.
    Clin Pharm; 1982 Jul; 1(3):207-16. PubMed ID: 6224627
    [Abstract] [Full Text] [Related]

  • 24. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C, Sageaux JC, Bebear C, Latrille J.
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Relative efficacy of carbenicillin indanyl sodium and of trimethoprim/sulfamethoxazole in urinary-tract infections.
    Seneca H.
    J Am Geriatr Soc; 1979 May; 27(5):222-4. PubMed ID: 581878
    [Abstract] [Full Text] [Related]

  • 31. Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection.
    Ries KM, Cobbs CG, Gillenwater JY, Levison ME, Mandell GL, Sande MA, Kaye D.
    Antimicrob Agents Chemother; 1973 Dec; 4(6):593-6. PubMed ID: 4602827
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Carbenicillin and ticarcillin.
    Neu HC.
    Med Clin North Am; 1982 Jan; 66(1):61-77. PubMed ID: 7038341
    [Abstract] [Full Text] [Related]

  • 35. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N, Rao P, Arora J, Dogra A.
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Susceptibility of gram-negative aerobic bacilli resistant to carbenicillin in a general hospital to piperacillin and ticarcillin.
    McGowan JE, Terry PM.
    Antimicrob Agents Chemother; 1979 Jan; 15(1):137-39. PubMed ID: 426501
    [Abstract] [Full Text] [Related]

  • 39. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC, Jenkins R, Matsen JM.
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [Abstract] [Full Text] [Related]

  • 40. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F.
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.